Universe Pharmaceuticals (UPC) Cash & Current Investments (2020 - 2024)
Historic Cash & Current Investments for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $29.5 billion.
- Universe Pharmaceuticals' Cash & Current Investments fell 446.27% to $29.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $29.5 billion, marking a year-over-year decrease of 446.27%. This contributed to the annual value of $29.5 billion for FY2025, which is 34270.09% up from last year.
- Latest data reveals that Universe Pharmaceuticals reported Cash & Current Investments of $29.5 billion as of Q3 2025, which was down 446.27% from $30.9 billion recorded in Q3 2024.
- In the past 5 years, Universe Pharmaceuticals' Cash & Current Investments registered a high of $30.9 billion during Q3 2024, and its lowest value of $11.4 million during Q1 2024.
- For the 5-year period, Universe Pharmaceuticals' Cash & Current Investments averaged around $8.9 billion, with its median value being $2.7 billion (2022).
- Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 2615591.52% in 2022, then plummeted by 4013.99% in 2024.
- Quarter analysis of 5 years shows Universe Pharmaceuticals' Cash & Current Investments stood at $21.8 million in 2021, then skyrocketed by 26155.92% to $5.7 billion in 2022, then decreased by 7.65% to $5.3 billion in 2023, then surged by 484.03% to $30.9 billion in 2024, then dropped by 4.46% to $29.5 billion in 2025.
- Its Cash & Current Investments was $29.5 billion in Q3 2025, compared to $30.9 billion in Q3 2024 and $11.4 million in Q1 2024.